1H NMR (400 MHz) d (CDCl3): 8.84 (d, 1H, J = 1.6 Hz,
C5H4N), 8.54 (dd, 1H, J = 4.8 Hz, 1.6 Hz, C5H4N), 7.84
(d of t, 1H, J = 8.4 Hz, 1.6 Hz, C5H4N), 7.45 (d, 2H, J = 8.3 Hz,
C6H4), 7.33 (dt, 1H, J = 8.4 Hz, 4.8 Hz, C5H4N), 7.30–7.26
(m, 4H, ortho-C6H5), 7.17–7.03 (m, 8H, meta-, para-C6H5,
C6H4); 13C NMR (100 MHz) 148.00, 147.92, 147.43, 136.13,
133.68, 131.25, 129.34, 127.74, 124.68, 123.55, 123.48, 123.27;
MS (EI 70 eV) m/z = 322[M+]; anal. calc. for C23H18N2: C,
85.68; H, 5.63; N, 8.69. Found C, 85.61; H, 5.57; N, 8.59%.
CH2Cl2–n-pentane giving yellow needles of 6 (132 mg,
92% yield).
1H NMR (400 MHz) d (CDCl3) 9.07 (d, 2H, J = 6.0 Hz,
C5H4N+), 8.08 (d, 2H, J = 6.0 Hz, C5H4N+), 7.65 (d, 2H,
J = 8.4 Hz, C6H4), 7.34–7.31 (m, 4H, ortho-C6H5), 7.18–7.13
(m, 6H, meta-, para-C6H5), 7.03 (d, 2H, J = 8.4 Hz, C6H4),
4.53 (s, 3H, CH3); 13C NMR (100 MHz) 154.85, 145.75,
144.79, 129.76, 129.02, 126.19, 125.29, 123.87, 122.66,
120.27, 47.94; MS FAB (+ve, nba) m/z = 337 [M+]; anal.
calc. for C24H21N2I: C, 62.08; H, 4.56; N, 6.03. Found C,
61.98; H, 4.51; N, 5.94%.
Synthesis of 3
A similar procedure to the synthesis of 2 was followed except
that 1-iodo-4-nitrobenzene (249.0 mg, 1.0 mmol) was utilised.
3 was isolated as red-orange crystals (yield 293 mg, 80%).
1H NMR (400 MHz) d (CDCl3) 8.26 (d, 2H, J = 8.8 Hz,
C6H4NO2), 7.69 (d, 2H, J = 8.8 Hz, C6H4NO2), 7.50 (d, 2H,
J = 8.4 Hz, C6H4), 7.32–7.27 (m, 4H, ortho-C6H5), 7.16–7.06
(m, 8H, meta-, para-C6H5, C6H4); 13C NMR (100 MHz)
148.86, 147.18, 147.04, 146.49, 131.56, 129.45, 128.05,
126.85, 125.05, 124.17, 123.70, 122.82; MS (EI 70 eV) m/z =
366 [M+], 320 [M+ À NO2]; HRMS: m/z = 366.1368 (calc.
for C24H18N2O2: 366.1368); anal. calc. for C24H18N2O2: C,
78.67; H, 4.95; N, 7.65. Found C, 78.60; H, 4.89; N, 7.61%.
Synthesis of 7
1 (100 mg, 0.30 mmol) was dissolved in methyl iodide (7 ml).
The solution was stirred for 30 min at room temperature and
the product precipitated as a yellow solid. After filtration and
washing with Et2O, the crude product was recrystallised from
CH2Cl2–n-pentane giving yellow needles of 7 (120 mg, 83%
yield).
1H NMR (400 MHz) d (CDCl3) 9.32 (s, 1H, C5H4N), 9.03
(d, 1H, J = 5.6 Hz, C5H4N), 8.47 (d, 1H, J = 8.42 Hz,
C5H4N), 8.03 (dd, 1H, J = 5.6 Hz, 4.0 Hz, C5H4N), 7.68
(d, 2H, J = 8.9 Hz, C6H4), 7.33–7.25 (m, 4H, ortho-C6H5),
7.15–7.07 (m, 8H, meta-, para-C6H5, C6H4), 4.74 (s, 3H, CH3);
MS FAB (+ve, nba) m/z = 337 [M+]; anal. calc. for
C24H21N2I: C, 62.08; H, 4.56; N, 6.03. Found C, 61.99; H,
4.47; N, 5.93%
Synthesis of 4
A similar procedure to the synthesis of 2 was followed except
that 4-iodobenzaldehyde (232.0 mg, 1.0 mmol) was utilised. 4
was isolated as red-orange crystals (yield 297 mg, 82%).
1H NMR (270 MHz) d (CDCl3) 10.02 (s, 1H, CHO), 7.92
(d, 2H, J = 8.1 Hz, C7H5O), 7.72 (d, 2H, J = 8.1 Hz, C7H5O),
7.51 (d, 2H, J = 8.6 Hz, C6H4), 7.32–7.25 (m, 4H, ortho-
C6H5), 7.15–7.04 (m, 8H, meta-, para-C6H5, C6H4); IR
(KBr, cmÀ1): 1691; MS (EI 70 eV) m/z = 349 [M+]; HRMS
m/z = 349.1464 (calc. for C25H19NO: 349.1466); anal. calc. for
C25H19NO: C, 85.93; H, 5.48; N, 4.01. Found C, 85.87; H,
5.64; N, 3.95%.
Synthesis of 8
A mixture of 1 (100 mg, 0.30 mmol) and 1-iodooctane (7 ml)
was heated for 16 h at 70 1C. The product precipitated as a
yellow solid, and after filtration under reduced pressure and
washing with Et2O, it was recrystallised from CH2Cl2–
n-pentane giving yellow needles of 8 (140 mg, 80% yield).
1H NMR (400 MHz) d (CDCl3) 9.11 (d, 2H, J = 7.2 Hz,
C5H4N+), 8.10 (d, 2H, J = 7.2 Hz, C5H4N+), 7.66 (d, 2H,
J = 8.8 Hz, C6H4), 7.37–7.33 (m, 4H, ortho-C6H5), 7.18–7.15
(m, 6H, meta-, para-C6H5), 7.05 (d, 2H, J = 8.8 Hz, C6H4),
4.75 (t, 2H, J = 7.6 Hz, N+CH2(CH2)6CH3), 2.04–1.96
(m, N+CH2(CH2)6CH3), 1.41–1.16 (m, N+CH2(CH2)6CH3),
0.84 (t, 3H, J = 6.8 Hz, N+CH2(CH2)6CH3); 13C NMR
(100 MHz) 154.98, 145.75, 143.94, 129.81, 129.04, 126.27,
125.39, 123.82, 122.76, 120. 24, 60.63, 31.62, 28.98, 28.96,
16.02, 22.53, 14.01; MS FAB (+ve, nba) m/z = 435 [M+], 322
[M+ À C8H17]; anal. calc. for C31H35N2I: C, 66.19; H, 6.27; N,
4.98. Found C, 66.15; H, 6.26; N, 4.92%.
Synthesis of 5
A similar procedure to the synthesis of 2 was followed except
that 4-iodo-acetophenone (246.0 mg, 1.0 mmol) was utilised. 5
was isolated as red-orange crystals (yield 308 mg, 85%).
1H NMR (400 MHz) d (CDCl3) 8.01 (d, 2H, J = 8.0 Hz,
C8H7O), 7.66 (d, 2H, J = 8.0 Hz, C8H7O), 7.52 (d, 2H,
J
= 8.4 Hz, C6H4), 7.31–7.26 (m, 4H, ortho-C6H5),
7.16–7.05 (m, 8H, meta-, para-C6H5, C6H4), 2.63 (s, 3H,
CH3); 13C NMR (100 MHz) 197.56, 148.13, 147.36, 145.13,
135.28, 133.07, 129.33, 128.91, 127.86, 126.42, 124.73, 123.31,
123.23, 26.55; IR (KBr, cmÀ1): 1678; MS (EI 70 eV) m/z = 363
Synthesis of 9
To finely powdered 1 (200 mg, 0.60 mmol) concentrated HCl
solution (40 ml) was added. The resulting suspension was
sonicated and then stirred at room temperature for 30 min.
Upon stirring colourless 1 was slowly dissolved to form a
yellow solution. Removal of the solvent in vacuo effected
precipitation of a yellow solid which was filtered off and dried
under vacuum overnight. The crude product was recrystallised
from CH2Cl2–n-pentane giving yellow needles of 9 (345 mg);
anal. calc. for C23H19N2ClÁ2CH2Cl2ÁH2O: C, 54.92; H, 4.61;
N, 5.12. Found C, 55.12; H, 4.91; N, 5.13%.
[M+]; HRMS m/z
= 363.1617 (calc. for C26H21NO:
363.1623); anal. calc. for C26H21NO: C, 85.92; H, 5.82; N,
3.85. Found C, 85.93; H, 5.86; N, 3.79%.
Synthesis of 6
1 (100 mg, 0.30 mmol) was dissolved in methyl iodide (7 ml).
The solution was stirred for 30 min at room temperature and
the product precipitated as a yellow solid. After filtration and
washing with Et2O, the crude product was recrystallised from
ꢀc
This journal is The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2009
New J. Chem., 2009, 33, 598–606 | 605